
The National Head of Account Management offers a meaningful leadership opportunity to deliver the field strategy and execution for commercial launch of an allogeneic cell therapy, Tabelecleucel (tab-cel). The incumbent is responsible for the achievement of national sales targets and the performance of the account team. This role will shape critical components of the commercial strategy such as the development of the treatment site activation strategy, customer engagement model, leadership and development out of the cell therapy account team and the team’s execution to ensure appropriate patients can benefit from this innovative product post approval. This role will be part of the Commercial leadership team and work closely with the CCO, Head of Value an Access and other cross functional leaders to ensure efficient operational execution supporting appropriate patient treatment.
The ideal candidate is a Purpose-driven, agile leader, with a strong entrepreneurial spirit, collaborative mindset, high self awareness and emotional intelligence with a demonstrated ability to inspire high-performing teams in a scaling organization. This role will report to the Senior Vice President, head of commercial and be a core member of the US Commercial Leadership Team.
ESSENTIAL FUNCTIONS:
Sales Leadership and Drive for Performance:
Team Leadership:
Stakeholder Engagement and Customer Centricity
Compliance and Reporting:
Other duties and responsibilities may be assigned as required based on evolving business needs.
REQUIRED EDUCATION AND EXPERIENCE:
PREFERRED EDUCATION AND EXPERIENCE:
WORK ENVIRONMENT:
LOCATION US - National, remote.
Compensation and Benefits:
Anticipated Salary Range: $250,000 - $340,000
This range represents the base annual full-time salary for all positions within the applicable job grade. The actual salary offer will depend on a range of factors including experience, education, location, and other relevant qualifications. This position is also eligible for a Pierre Fabre bonus, commission, or incentive program in addition to the base pay.
Employees will be eligible to participate in a comprehensive benefits package that includes medical, dental, and vision coverage, voluntary benefits, a 401(k) retirement plan, a generous PTO policy, paid company holidays, and paid parental leave. Additional offerings include employee discounts on our products, professional development opportunities, and access to mental health and wellness programs
Pierre Fabre is an equal employment opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law.
We are convinced that diversity is a source of fulfillment, social balance and complementarity for our employees, which is why our offers are open to all, without restriction.

Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.
This makes Pierre Fabre Group :
💊 A pharmaceutical group with a strong positioning : medical and natural
🥈 The second largest dermo-cosmetics laboratory in the world
🥈 The second largest private French pharmaceutical group
🥇 The market leader in France for products sold over the counter in pharmacies.
Our portfolio includes several medical franchises and international brands including ;
Pharmaceutical Care
Pierre Fabre Oncologie
Pierre Fabre Dermatologie
Naturactive
Eau Thermale Avène
Klorane
Ducray
René Furterer
A-Derma
Pierre Fabre Oral Care
Glytone (US)
Darrow (Brasil)
Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.
Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business.
Pierre Fabre Group has a unique company structure.
86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.
In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.